Back to Search
BENJAMIN ALGER, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1780921502Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus.
PMID 19339609·J Neurosci·2009
7-preclinical
Novel mGluR- and CB1R-independent suppression of GABA release caused by a contaminant of the group I metabotropic glutamate receptor agonist, DHPG.
PMID 19568435·PLoS One·2009
7-preclinical
Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus.
PMID 18523004·Proc Natl Acad Sci U S A·2008
7-preclinical
Endocannabinoid modulation of fear responses: learning and state-dependent performance effects.
PMID 18308796·J Psychopharmacol·2008
7-preclinical
Distinctions among GABAA and GABAB responses revealed by calcium channel antagonists, cannabinoids, opioids, and synaptic plasticity in rat hippocampus.
PMID 18097653·Psychopharmacology (Berl)·2008
7-preclinical
Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.
PMID 17689570·Neuropharmacology·2008
7-preclinical
Ryanodine receptor regulates endogenous cannabinoid mobilization in the hippocampus.
PMID 16467427·J Neurophysiol·2006
4-observational
Multiple mechanisms of endocannabinoid response initiation in hippocampus.
PMID 16207781·J Neurophysiol·2006
7-preclinical
Endocannabinoid signaling dynamics probed with optical tools.
PMID 16221855·J Neurosci·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 855 MONO WAY
SONORA, CA 95370 - Phone
- (209) 588-0561
Quick Facts
- NPI
- 1780921502
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile